Report cover image

Central Nervous System Therapeutics Global Market Report 2025

Published Sep 30, 2025
Length 250 Pages
SKU # BRC20428478

Description

Central Nervous System Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on central nervous system therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for central nervous system therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The central nervous system therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Drug Class: Anesthetics; Anticonvulsants; Antiemetics; Central Nervous System (CNS) Stimulants; Pain Relievers; Other Drug Classes

2) By Disease: Neurovascular Diseases; Mental Health; Degenerative Disorders; Genetic Diseases; Substance Abuse Disorders; Autoimmune And Inflammatory Diseases; Central Nervous System (CNS) Trauma; Infectious Diseases; Central Nervous System (CNS) Cancer; Other Diseases

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels

4) By Application: Hospital; Clinic; Homecare; Other Applications

Subsegments:

1) By Anesthetics: General Anesthetics; Local Anesthetics; Dissociative Anesthetics; Inhalation Anesthetics; Intravenous Anesthetics

2) By Anticonvulsants: Sodium Channel Blockers; GABA Enhancers; Calcium Channel Blockers; SV2A Modulators; Mixed Mechanism Agents

3) By Antiemetics: Serotonin 5-HT3 Antagonists; Dopamine Antagonists; Neurokinin-1 (NK1) Receptor Antagonists; Antihistamines; Cannabinoids

4) By Central Nervous System (CNS) Stimulants: Amphetamines; Methylphenidates; Modafinil and Armodafinil; Caffeine-Based Stimulants; Xanthine Derivatives

5) By Pain Relievers: Opioid Analgesics; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Antidepressants for Neuropathic Pain; Anticonvulsants for Pain Relief; Topical Agents

6) By Other Drug Classes: Antipsychotics; Antidepressants; Muscle Relaxants; Sedatives and Hypnotics; Neuroprotective Agents

Companies Mentioned: Biogen Inc.; Otsuka Pharmaceutical Co Ltd.; UCB S.A.; Jazz Pharmaceuticals plc; Supernus Pharmaceuticals Inc.; Biohaven Ltd.; Acadia Pharmaceuticals Inc.; Neumora Therapeutics Inc.; Cerevel Therapeutics LLC; Axsome Therapeutics Inc.; TauRx Therapeutics Ltd.; Kyverna Therapeutics Inc.; Immunic Inc.; LEXEO Therapeutics Inc.; Autobahn Therapeutics; BrainStorm Cell Therapeutics Inc.; Progentos Therapeutics Inc.; Tonix Pharmaceuticals Holding Corp.; Neuroplast B.V.; Assertio Holdings Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. Central Nervous System Therapeutics Market Characteristics
3. Central Nervous System Therapeutics Market Trends And Strategies
4. Central Nervous System Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Central Nervous System Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Central Nervous System Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Central Nervous System Therapeutics Market Growth Rate Analysis
5.4. Global Central Nervous System Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Central Nervous System Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Central Nervous System Therapeutics Total Addressable Market (TAM)
6. Central Nervous System Therapeutics Market Segmentation
6.1. Global Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anesthetics
Anticonvulsants
Antiemetics
Central Nervous System (CNS) Stimulants
Pain Relievers
Other Drug Classes
6.2. Global Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Neurovascular Diseases
Mental Health
Degenerative Disorders
Genetic Diseases
Substance Abuse Disorders
Autoimmune And Inflammatory Diseases
Central Nervous System (CNS) Trauma
Infectious Diseases
Central Nervous System (CNS) Cancer
Other Diseases
6.3. Global Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channel
6.4. Global Central Nervous System Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Clinic
Homecare
Other Applications
6.5. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Anesthetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
General Anesthetics
Local Anesthetics
Dissociative Anesthetics
Inhalation Anesthetics
Intravenous Anesthetics
6.6. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sodium Channel Blockers
GABA Enhancers
Calcium Channel Blockers
SV2A Modulators
Mixed Mechanism Agents
6.7. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Antiemetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serotonin 5-HT3 Antagonists
Dopamine Antagonists
Neurokinin-1 NK1 Receptor Antagonists
Antihistamines
Cannabinoids
6.8. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Central Nervous System (CNS) Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Amphetamines
Methylphenidates
Modafinil And Armodafinil
Caffeine Based Stimulants
Xanthine Derivatives
6.9. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Pain Relievers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Opioid Analgesics
Non Steroidal AntiInflammatory Drugs NSAIDs
Antidepressants For NeuropathicPain
Anticonvulsants For Pain Relief
Topical Agents
6.10. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antipsychotics
Antidepressants
Muscle Relaxants
Sedatives And Hypnotics
Neuroprotective Agents
7. Central Nervous System Therapeutics Market Regional And Country Analysis
7.1. Global Central Nervous System Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Central Nervous System Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Central Nervous System Therapeutics Market
8.1. Asia-Pacific Central Nervous System Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Central Nervous System Therapeutics Market
9.1. China Central Nervous System Therapeutics Market Overview
9.2. China Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Central Nervous System Therapeutics Market
10.1. India Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Central Nervous System Therapeutics Market
11.1. Japan Central Nervous System Therapeutics Market Overview
11.2. Japan Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Central Nervous System Therapeutics Market
12.1. Australia Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Central Nervous System Therapeutics Market
13.1. Indonesia Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Central Nervous System Therapeutics Market
14.1. South Korea Central Nervous System Therapeutics Market Overview
14.2. South Korea Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Central Nervous System Therapeutics Market
15.1. Western Europe Central Nervous System Therapeutics Market Overview
15.2. Western Europe Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Central Nervous System Therapeutics Market
16.1. UK Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Central Nervous System Therapeutics Market
17.1. Germany Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Central Nervous System Therapeutics Market
18.1. France Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Central Nervous System Therapeutics Market
19.1. Italy Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Central Nervous System Therapeutics Market
20.1. Spain Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Central Nervous System Therapeutics Market
21.1. Eastern Europe Central Nervous System Therapeutics Market Overview
21.2. Eastern Europe Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Central Nervous System Therapeutics Market
22.1. Russia Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Central Nervous System Therapeutics Market
23.1. North America Central Nervous System Therapeutics Market Overview
23.2. North America Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Central Nervous System Therapeutics Market
24.1. USA Central Nervous System Therapeutics Market Overview
24.2. USA Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Central Nervous System Therapeutics Market
25.1. Canada Central Nervous System Therapeutics Market Overview
25.2. Canada Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Central Nervous System Therapeutics Market
26.1. South America Central Nervous System Therapeutics Market Overview
26.2. South America Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Central Nervous System Therapeutics Market
27.1. Brazil Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Central Nervous System Therapeutics Market
28.1. Middle East Central Nervous System Therapeutics Market Overview
28.2. Middle East Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Central Nervous System Therapeutics Market
29.1. Africa Central Nervous System Therapeutics Market Overview
29.2. Africa Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Central Nervous System Therapeutics Market Competitive Landscape And Company Profiles
30.1. Central Nervous System Therapeutics Market Competitive Landscape
30.2. Central Nervous System Therapeutics Market Company Profiles
30.2.1. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Otsuka Pharmaceutical Co Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. UCB S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Jazz Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Supernus Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Central Nervous System Therapeutics Market Other Major And Innovative Companies
31.1. Biohaven Ltd.
31.2. Acadia Pharmaceuticals Inc.
31.3. Neumora Therapeutics Inc.
31.4. Cerevel Therapeutics LLC
31.5. Axsome Therapeutics Inc.
31.6. TauRx Therapeutics Ltd.
31.7. Kyverna Therapeutics Inc.
31.8. Immunic Inc.
31.9. LEXEO Therapeutics Inc.
31.10. Autobahn Therapeutics
31.11. BrainStorm Cell Therapeutics Inc.
31.12. Progentos Therapeutics Inc.
31.13. Tonix Pharmaceuticals Holding Corp.
31.14. Neuroplast B.V.
31.15. Assertio Holdings Inc. 
32. Global Central Nervous System Therapeutics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Central Nervous System Therapeutics Market
34. Recent Developments In The Central Nervous System Therapeutics Market
35. Central Nervous System Therapeutics Market High Potential Countries, Segments and Strategies
35.1 Central Nervous System Therapeutics Market In 2029 - Countries Offering Most New Opportunities
35.2 Central Nervous System Therapeutics Market In 2029 - Segments Offering Most New Opportunities
35.3 Central Nervous System Therapeutics Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.